Supplemental Consolidating Data - Schedule of Cash Flows (Details) - USD ($)
$ in Thousands |
3 Months Ended |
6 Months Ended |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
| Cash flows from operating activities: |
|
|
|
|
|
|
| Net income |
$ 78,981
|
$ 24,123
|
$ 105,745
|
$ 130,797
|
$ 103,105
|
$ 236,542
|
| Adjustments to reconcile Net income to Net cash (used) provided by operating activities: |
|
|
|
|
|
|
| Depreciation and amortization |
|
|
|
|
86,703
|
82,129
|
| Amortization of deferred loan origination costs |
|
|
|
|
4,804
|
32,489
|
| Amortization of financing origination fees |
|
|
|
|
2,485
|
6,630
|
| Income related to long-term employee benefits |
|
|
|
|
(20,424)
|
(27,526)
|
| Employee benefit plan contributions and payments |
|
|
|
|
(2,975)
|
(3,256)
|
| Stock compensation expense |
|
|
|
|
18,034
|
17,407
|
| Net change in wholesale finance receivables related to sales |
|
|
|
|
(80,003)
|
(145,174)
|
| Provision for credit losses |
|
|
|
|
30,796
|
103,072
|
| Collections from finance receivables held for sale |
|
|
|
|
74,760
|
0
|
| Proceeds from sale of finance receivables held for sale |
|
|
|
|
761,221
|
0
|
| Originations of finance receivables held for sale |
|
|
|
|
(1,181,674)
|
|
| Deferred income taxes |
|
|
|
|
(3,208)
|
13,856
|
| Other, net |
|
|
|
|
15,290
|
1,592
|
| Changes in current assets and liabilities: |
|
|
|
|
|
|
| Accounts receivable, net |
|
|
|
|
(81,214)
|
(66,851)
|
| Finance receivables – accrued interest and other |
|
|
|
|
(4,721)
|
4,999
|
| Inventories, net |
|
|
|
|
221,794
|
142,996
|
| Accounts payable and accrued liabilities |
|
|
|
|
5,360
|
136,098
|
| Other current assets |
|
|
|
|
(9,818)
|
(25,511)
|
| Total adjustments |
|
|
|
|
(162,790)
|
272,950
|
| Net cash (used) provided by operating activities |
|
|
|
|
(59,685)
|
509,492
|
| Cash flows from investing activities: |
|
|
|
|
|
|
| Capital expenditures |
|
|
|
|
(44,694)
|
(65,560)
|
| Origination of finance receivables held for investment |
|
|
|
|
(872,661)
|
(1,765,951)
|
| Collections on finance receivables held for investment |
|
|
|
|
575,863
|
1,740,966
|
| Collection of retained securitization beneficial interests |
|
|
|
|
23,460
|
0
|
| Proceeds from derivative instruments |
|
|
|
|
51,574
|
0
|
| Other investing activities |
|
|
|
|
(280)
|
691
|
| Net cash (used) provided by investing activities |
|
|
|
|
(266,738)
|
(89,854)
|
| Cash flows from financing activities: |
|
|
|
|
|
|
| Proceeds from issuance of medium-term notes |
|
|
|
|
0
|
647,088
|
| Repayments of medium-term notes |
|
|
|
|
(810,950)
|
(700,000)
|
| Proceeds from securitization debt |
|
|
|
|
0
|
497,790
|
| Repayments of securitization debt |
|
|
|
|
0
|
(584,153)
|
| Borrowings of asset-backed commercial paper |
|
|
|
|
0
|
155,000
|
| Repayments of asset-backed commercial paper |
|
|
|
|
0
|
(145,379)
|
| Net increase in unsecured commercial paper |
|
|
|
|
114,102
|
(135,902)
|
| Net increase (decrease) in deposits |
|
|
|
|
(20,554)
|
(13,073)
|
| Dividends paid |
|
|
|
|
(41,211)
|
(44,756)
|
| Repurchase of common stock |
|
|
|
|
(100,388)
|
(93,140)
|
| Other financing activities |
|
|
|
|
97
|
6
|
| Net cash used by financing activities |
|
|
|
|
(858,904)
|
(416,519)
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
|
|
(10,628)
|
12,375
|
| Net (decrease) increase in cash, cash equivalents and restricted cash |
|
|
|
|
(1,195,955)
|
15,494
|
| Cash, cash equivalents and restricted cash: |
|
|
|
|
|
|
| Cash, cash equivalents and restricted cash, beginning of period |
|
3,091,744
|
|
1,740,854
|
3,091,744
|
1,740,854
|
| Net decrease in cash, cash equivalents and restricted cash |
|
|
|
|
(1,195,955)
|
15,494
|
| Cash, cash equivalents and restricted cash, end of period |
1,895,789
|
|
1,756,348
|
|
1,895,789
|
1,756,348
|
| Reportable Legal Entities | Non-Financial Services Entities |
|
|
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
|
|
| Net income |
163,137
|
|
53,807
|
|
170,553
|
136,346
|
| Adjustments to reconcile Net income to Net cash (used) provided by operating activities: |
|
|
|
|
|
|
| Depreciation and amortization |
|
|
|
|
85,311
|
77,352
|
| Amortization of deferred loan origination costs |
|
|
|
|
0
|
0
|
| Amortization of financing origination fees |
|
|
|
|
64
|
364
|
| Income related to long-term employee benefits |
|
|
|
|
(20,424)
|
(27,526)
|
| Employee benefit plan contributions and payments |
|
|
|
|
(2,975)
|
(3,256)
|
| Stock compensation expense |
|
|
|
|
17,219
|
16,246
|
| Net change in wholesale finance receivables related to sales |
|
|
|
|
0
|
0
|
| Provision for credit losses |
|
|
|
|
0
|
0
|
| Collections from finance receivables held for sale |
|
|
|
|
0
|
|
| Proceeds from sale of finance receivables held for sale |
|
|
|
|
0
|
|
| Originations of finance receivables held for sale |
|
|
|
|
0
|
|
| Deferred income taxes |
|
|
|
|
4,129
|
11,955
|
| Other, net |
|
|
|
|
16,675
|
(18,648)
|
| Changes in current assets and liabilities: |
|
|
|
|
|
|
| Accounts receivable, net |
|
|
|
|
(333,774)
|
(282,732)
|
| Finance receivables – accrued interest and other |
|
|
|
|
0
|
0
|
| Inventories, net |
|
|
|
|
221,794
|
142,996
|
| Accounts payable and accrued liabilities |
|
|
|
|
54,870
|
95,281
|
| Other current assets |
|
|
|
|
(50,865)
|
6,156
|
| Total adjustments |
|
|
|
|
(7,976)
|
18,188
|
| Net cash (used) provided by operating activities |
|
|
|
|
162,577
|
154,534
|
| Cash flows from investing activities: |
|
|
|
|
|
|
| Capital expenditures |
|
|
|
|
(44,594)
|
(65,330)
|
| Origination of finance receivables held for investment |
|
|
|
|
0
|
0
|
| Collections on finance receivables held for investment |
|
|
|
|
0
|
0
|
| Collection of retained securitization beneficial interests |
|
|
|
|
0
|
|
| Proceeds from derivative instruments |
|
|
|
|
0
|
|
| Other investing activities |
|
|
|
|
(280)
|
691
|
| Net cash (used) provided by investing activities |
|
|
|
|
(44,874)
|
(64,639)
|
| Cash flows from financing activities: |
|
|
|
|
|
|
| Proceeds from issuance of medium-term notes |
|
|
|
|
|
0
|
| Repayments of medium-term notes |
|
|
|
|
0
|
0
|
| Proceeds from securitization debt |
|
|
|
|
|
0
|
| Repayments of securitization debt |
|
|
|
|
|
0
|
| Borrowings of asset-backed commercial paper |
|
|
|
|
|
0
|
| Repayments of asset-backed commercial paper |
|
|
|
|
|
0
|
| Net increase in unsecured commercial paper |
|
|
|
|
0
|
0
|
| Net increase (decrease) in deposits |
|
|
|
|
0
|
0
|
| Dividends paid |
|
|
|
|
(41,211)
|
(44,756)
|
| Repurchase of common stock |
|
|
|
|
(100,388)
|
(93,140)
|
| Other financing activities |
|
|
|
|
97
|
6
|
| Net cash used by financing activities |
|
|
|
|
(141,502)
|
(137,890)
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
|
|
(7,818)
|
9,678
|
| Net (decrease) increase in cash, cash equivalents and restricted cash |
|
|
|
|
(31,617)
|
(38,317)
|
| Cash, cash equivalents and restricted cash: |
|
|
|
|
|
|
| Cash, cash equivalents and restricted cash, beginning of period |
|
1,314,917
|
|
1,105,663
|
1,314,917
|
1,105,663
|
| Net decrease in cash, cash equivalents and restricted cash |
|
|
|
|
(31,617)
|
(38,317)
|
| Cash, cash equivalents and restricted cash, end of period |
1,283,300
|
|
1,067,346
|
|
1,283,300
|
1,067,346
|
| Reportable Legal Entities | Financial Services Entities |
|
|
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
|
|
| Net income |
15,869
|
|
52,192
|
|
32,533
|
100,243
|
| Adjustments to reconcile Net income to Net cash (used) provided by operating activities: |
|
|
|
|
|
|
| Depreciation and amortization |
|
|
|
|
1,392
|
4,777
|
| Amortization of deferred loan origination costs |
|
|
|
|
4,804
|
32,489
|
| Amortization of financing origination fees |
|
|
|
|
2,421
|
6,266
|
| Income related to long-term employee benefits |
|
|
|
|
0
|
0
|
| Employee benefit plan contributions and payments |
|
|
|
|
0
|
0
|
| Stock compensation expense |
|
|
|
|
815
|
1,161
|
| Net change in wholesale finance receivables related to sales |
|
|
|
|
0
|
0
|
| Provision for credit losses |
|
|
|
|
30,796
|
103,072
|
| Collections from finance receivables held for sale |
|
|
|
|
74,760
|
|
| Proceeds from sale of finance receivables held for sale |
|
|
|
|
761,221
|
|
| Originations of finance receivables held for sale |
|
|
|
|
(1,181,674)
|
|
| Deferred income taxes |
|
|
|
|
(7,097)
|
2,025
|
| Other, net |
|
|
|
|
(1,365)
|
20,195
|
| Changes in current assets and liabilities: |
|
|
|
|
|
|
| Accounts receivable, net |
|
|
|
|
0
|
0
|
| Finance receivables – accrued interest and other |
|
|
|
|
(4,721)
|
4,999
|
| Inventories, net |
|
|
|
|
0
|
0
|
| Accounts payable and accrued liabilities |
|
|
|
|
220,362
|
230,797
|
| Other current assets |
|
|
|
|
17,291
|
(10,497)
|
| Total adjustments |
|
|
|
|
(80,995)
|
395,284
|
| Net cash (used) provided by operating activities |
|
|
|
|
(48,462)
|
495,527
|
| Cash flows from investing activities: |
|
|
|
|
|
|
| Capital expenditures |
|
|
|
|
(100)
|
(230)
|
| Origination of finance receivables held for investment |
|
|
|
|
(2,370,945)
|
(3,203,305)
|
| Collections on finance receivables held for investment |
|
|
|
|
2,000,347
|
3,037,751
|
| Collection of retained securitization beneficial interests |
|
|
|
|
23,460
|
|
| Proceeds from derivative instruments |
|
|
|
|
51,574
|
|
| Other investing activities |
|
|
|
|
0
|
0
|
| Net cash (used) provided by investing activities |
|
|
|
|
(295,664)
|
(165,784)
|
| Cash flows from financing activities: |
|
|
|
|
|
|
| Proceeds from issuance of medium-term notes |
|
|
|
|
|
647,088
|
| Repayments of medium-term notes |
|
|
|
|
(810,950)
|
(700,000)
|
| Proceeds from securitization debt |
|
|
|
|
|
497,790
|
| Repayments of securitization debt |
|
|
|
|
|
(584,153)
|
| Borrowings of asset-backed commercial paper |
|
|
|
|
|
155,000
|
| Repayments of asset-backed commercial paper |
|
|
|
|
|
(145,379)
|
| Net increase in unsecured commercial paper |
|
|
|
|
114,102
|
(135,902)
|
| Net increase (decrease) in deposits |
|
|
|
|
(20,554)
|
(13,073)
|
| Dividends paid |
|
|
|
|
(100,000)
|
0
|
| Repurchase of common stock |
|
|
|
|
0
|
0
|
| Other financing activities |
|
|
|
|
0
|
0
|
| Net cash used by financing activities |
|
|
|
|
(817,402)
|
(278,629)
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
|
|
(2,810)
|
2,697
|
| Net (decrease) increase in cash, cash equivalents and restricted cash |
|
|
|
|
(1,164,338)
|
53,811
|
| Cash, cash equivalents and restricted cash: |
|
|
|
|
|
|
| Cash, cash equivalents and restricted cash, beginning of period |
|
1,776,827
|
|
635,191
|
1,776,827
|
635,191
|
| Net decrease in cash, cash equivalents and restricted cash |
|
|
|
|
(1,164,338)
|
53,811
|
| Cash, cash equivalents and restricted cash, end of period |
612,489
|
|
689,002
|
|
612,489
|
689,002
|
| Consolidating Adjustments |
|
|
|
|
|
|
| Cash flows from operating activities: |
|
|
|
|
|
|
| Net income |
(100,025)
|
|
(254)
|
|
(99,981)
|
(47)
|
| Adjustments to reconcile Net income to Net cash (used) provided by operating activities: |
|
|
|
|
|
|
| Depreciation and amortization |
|
|
|
|
0
|
0
|
| Amortization of deferred loan origination costs |
|
|
|
|
0
|
0
|
| Amortization of financing origination fees |
|
|
|
|
0
|
0
|
| Income related to long-term employee benefits |
|
|
|
|
0
|
0
|
| Employee benefit plan contributions and payments |
|
|
|
|
0
|
0
|
| Stock compensation expense |
|
|
|
|
0
|
0
|
| Net change in wholesale finance receivables related to sales |
|
|
|
|
(80,003)
|
(145,174)
|
| Provision for credit losses |
|
|
|
|
0
|
0
|
| Collections from finance receivables held for sale |
|
|
|
|
0
|
|
| Proceeds from sale of finance receivables held for sale |
|
|
|
|
0
|
|
| Originations of finance receivables held for sale |
|
|
|
|
0
|
|
| Deferred income taxes |
|
|
|
|
(240)
|
(124)
|
| Other, net |
|
|
|
|
(20)
|
45
|
| Changes in current assets and liabilities: |
|
|
|
|
|
|
| Accounts receivable, net |
|
|
|
|
252,560
|
215,881
|
| Finance receivables – accrued interest and other |
|
|
|
|
0
|
0
|
| Inventories, net |
|
|
|
|
0
|
0
|
| Accounts payable and accrued liabilities |
|
|
|
|
(269,872)
|
(189,980)
|
| Other current assets |
|
|
|
|
23,756
|
(21,170)
|
| Total adjustments |
|
|
|
|
(73,819)
|
(140,522)
|
| Net cash (used) provided by operating activities |
|
|
|
|
(173,800)
|
(140,569)
|
| Cash flows from investing activities: |
|
|
|
|
|
|
| Capital expenditures |
|
|
|
|
0
|
0
|
| Origination of finance receivables held for investment |
|
|
|
|
1,498,284
|
1,437,354
|
| Collections on finance receivables held for investment |
|
|
|
|
(1,424,484)
|
(1,296,785)
|
| Collection of retained securitization beneficial interests |
|
|
|
|
0
|
|
| Proceeds from derivative instruments |
|
|
|
|
0
|
|
| Other investing activities |
|
|
|
|
0
|
0
|
| Net cash (used) provided by investing activities |
|
|
|
|
73,800
|
140,569
|
| Cash flows from financing activities: |
|
|
|
|
|
|
| Proceeds from issuance of medium-term notes |
|
|
|
|
|
0
|
| Repayments of medium-term notes |
|
|
|
|
0
|
0
|
| Proceeds from securitization debt |
|
|
|
|
|
0
|
| Repayments of securitization debt |
|
|
|
|
|
0
|
| Borrowings of asset-backed commercial paper |
|
|
|
|
|
0
|
| Repayments of asset-backed commercial paper |
|
|
|
|
|
0
|
| Net increase in unsecured commercial paper |
|
|
|
|
0
|
0
|
| Net increase (decrease) in deposits |
|
|
|
|
0
|
0
|
| Dividends paid |
|
|
|
|
100,000
|
0
|
| Repurchase of common stock |
|
|
|
|
0
|
0
|
| Other financing activities |
|
|
|
|
0
|
0
|
| Net cash used by financing activities |
|
|
|
|
100,000
|
0
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
|
|
0
|
0
|
| Net (decrease) increase in cash, cash equivalents and restricted cash |
|
|
|
|
0
|
0
|
| Cash, cash equivalents and restricted cash: |
|
|
|
|
|
|
| Cash, cash equivalents and restricted cash, beginning of period |
|
$ 0
|
|
$ 0
|
0
|
0
|
| Net decrease in cash, cash equivalents and restricted cash |
|
|
|
|
0
|
0
|
| Cash, cash equivalents and restricted cash, end of period |
$ 0
|
|
$ 0
|
|
$ 0
|
$ 0
|